Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ANG Lifesciences India Ltd - 540694 - Unaudited Financial Result (Standalone And Consolidated) For The Quarter & Half Year Ended 30Th September, 2022.

 Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 please find enclosed as follow: (1) Unaudited financial result (standalone and consolidated) as per India Accounting Standards for the quarter & half year ended 30th September 2022; and (2) Limited review report (standalone and consolidated) by M/s Raman Wadhwa & Co., Statutory Auditor of the Company.
14-11-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Unaudited Financial Result (Standalone And Consolidated) For The Quarter & Half Year Ended 30Th September, 2022.

 The Board of Directors of the Company at its meeting held on today i.e. 14th November, 2022, has inter-alia approved the Unaudited Financial Result (standalone & consolidated) for the quarter & half year ended 30th September, 2022.
14-11-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Disclosure Of E-Voting Result Of EGM Held On 10.11.2022

 We furnish herewith the results of remote e-voting & remote e-voting conducted at the Extra Ordinary General Meeting of the Company held on Thursday, 10th November, 2022, in respect of items of business;/agendas mentioned in Notice dated 17th October, 2022 ("EGM Notice") in the form prescribed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
12-11-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Outcome Of Extra Ordinary General Meeting Dated 10.11.2022

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the summary of proceedings of the Extra Ordinary General Meeting (EGM) held on Thursday, November, 10, 2022, at 12:00 p.m. through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM") in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India for transacting the business(es) mentioned in the Notice dated 17th October, 2022 convening the EGM.
11-11-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 14th, 2022 at 4:30 PM to transact the agenda as per document enclosed.
05-11-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of Newspaper Advertisement published on 20' October, 2022, one in the English Newspaper having nationwide circulation -Financial Express and one in Vernacular Newspaper - Desh Sewak intimating the) shareholders about Extra Ordinary General Meeting of our company to be held on 10' November, 2022 at 12:00 P.M through Video Conferencing/other Audio-Visual Means (OAVM).
20-10-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Notice Of Extra Ordinary General Meeting Of The Company

 Pursuant to Regulation 30 read with Part A of Schedule III, we are enclosing herewith a copy of notice of the Extra Ordinary General Meeting (EGM) of ANG Lifesciences India Ltd ("the Company'') to be held on Thursday, 10th November 2022 at 12:00 p.m. (IST) through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM").
18-10-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting And Disclosure Of Event Or Information Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that the Board of Directors of the Company in its meeting held on today, 17th October, 2022 at its registered office at SCO 113, Darbara Complex, First Floor, District Shopping Centre B Block, Ranjit Avenue, Amritsar, Punjab, 143001, have considered and approved the matters as enclosed herewith the Outcome of Board Meeting.
17-10-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Renu KaurDesignation :- Company Secretary and Compliance Officer
12-10-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the captioned subject, we hereby submit the confirmation Certificate received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations, 2018 for the Quarter ended on 30th September, 2022.
12-10-2022
Next Page
Close

Let's Open Free Demat Account